Bristol-Myers ends hepatitis C drug development
(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
Aug 24, 2012
0
0
(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
Aug 24, 2012
0
0
An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is ...
Aug 22, 2012
1
0
Doctors often prescribe drugs for people with mild high blood pressure with the hope of preventing cardiovascular disease (CVD). However, a new review from The Cochrane Library has found that this treatment does not reduce ...
Aug 15, 2012
0
0
The benefits of taking statins to reduce the risk of cardiovascular disease outweigh the increased risk of developing diabetes experienced by some patients who take these cholesterol-lowering drugs, according to an Article ...
Aug 9, 2012
1
0
More patients aged 75 and over should be prescribed drugs to help lower their risk of cardiovascular disease, a study published today in the British Medical Journal suggests.
Jul 12, 2012
0
0
Cholesterol-lowering statin drugs appear to be associated with reduced risk of recurrent cardiovascular events in men and women, but do not appear to be associated with reduced all-cause mortality or stroke in women, according ...
Jun 25, 2012
0
0
(HealthDay) -- It's not good news for baby boomers with arthritic knees: Injections of hyaluronic acid have little effect on pain and no effect on function, according to a new analysis.
Jun 12, 2012
0
0
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side effects, researchers ...
Jun 4, 2012
0
0
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
May 21, 2012
0
0
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
May 15, 2012
0
0